Abstract
We describe a 53-year-old patient with dermatomyositis, who developed pneumatosis intestinalis (PI) accompanied by pneumoperitoneum, pneumoretroperitoneum, pneumomediastinum, and subcutaneous emphysema of the neck. The development of PI in our patient was possibly attributed to the effect of factors such as dermatomyositis, corticosteroids, methotrexate, and alpha-glucosidase inhibitor (AGI). The coexistence of multiple factors associated with PI might enhance the risk of developing PI, even though each of them alone is not sufficient to induce it. In particular, the use of AGIs for patients treated with immunosuppressive agents such as corticosteroids requires evaluation.
References
Sequira W (1990) Pneumatosis cystoides intestinalis in systemic sclerosis and other disorders. Semin Arthritis Rheum 19:269–276
St Peter SD, Abbas MA, Kelly KA (2003) The spectrum of pneumatosis intestinalis. Arch Surg 138:68–75
Heng Y, Schuffler MD, Haggitt RC, Rohrmann CA (1995) Pneumatosis intestinalis: a review. Am J Gastroenterol 90:1747–1758
Cabrera GE, Scopelitis E, Cuellar ML, Silveira LH, Mena H, Espinoza LR (1994) Pneumatosis cystoides intestinalis in systemic lupus erythematosus with intestinal vasculitis: treatment with high dose prednisone. Clin Rheumatol 13:312–316
Pasquier E, Wattiaux MJ, Peigney N (1993) First case of pneumatosis cystoides intestinalis in adult dermatomyositis. J Rheumatol 20:499–503
Morris-Stiff GJ, Williams RJ (1999) Pneumatosis cystoides intestinalis in a patient with dermatomyositis. J R Soc Med 92:366–367
Vincent F, Duboust A, Glotz D (1995) Pneumatosis cystoides intestinalis and immunosuppression. Am J Gastroenterol 90:522–523
Ammons MA, Bauling PC, Weil R 3rd (1986) Pneumatosis cystoides intestinalis with pneumoperitoneum in renal transplant patients on cyclosporine and prednisone. Transplant Proc 18:1868–1870
Yanaru R, Hizawa K, Nakamura S, Yoshimura R, Watanabe K, Nakamura U et al (2002) Regression of pneumatosis cystoides intestinalis after discontinuing of alpha-glucosidase inhibitor administration. J Clin Gastroenterol 35:204–205
Joubert PH, Venter HL, Foukaridis GN (1990) The effect of miglitol and acarbose after an oral glucose load: a novel hypoglycaemic mechanism? Br J Clin Pharmacol 30:391–396
Forgacs P, Wright PH, Wyatt AP (1973) Treatment of intestinal gas cysts by oxygen breathing. Lancet 1:579–582
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Saito, M., Tanikawa, A., Nakasute, K. et al. Additive contribution of multiple factors in the development of pneumatosis intestinalis: a case report and review of the literature. Clin Rheumatol 26, 601–603 (2007). https://doi.org/10.1007/s10067-005-0179-9
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10067-005-0179-9